When and how to assess fast-changing technologies: A comparative study of medical applications of four generic technologies

Mowatt G, Bower DJ, Brebner JA, Cairns JA, Grant AM, McKee L
Record ID 31998008147
Authors' objectives:

To try to identify the optimal time at which to start assessing new and fast-evolving health technologies. To provide insight into the factors influencing the timing of assessments and the choice of methods for assessing new and fast-changing technologies.

Authors' recommendations: Assessment should be initiated early, using a variety of complementary assessment approaches. Methods of assessment and reporting should be more standardised from the earliest stages, to improve the usefulness and comparability of data. Resource issues should be incorporated into assessments from an early stage. All technologies should not be dealt with in the same way -they should be assigned to categories for which appropriate common triggers can be identified. Trials should be randomised from the outset. Assessments should be an iterative process. Citations and publication trends may be useful for identifying triggers.
Project Status: Completed
URL for project: http://www.hta.ac.uk/926
Year Published: 1997
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: England, United Kingdom
MeSH Terms
  • Breast Neoplasms
  • Cholecystectomy, Laparoscopic
  • Chorionic Villi Sampling
  • Cystic Fibrosis
  • Technology Assessment, Biomedical
  • Teleradiology
Organisation Name: NIHR Health Technology Assessment programme
Contact Address: NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name: journals.library@nihr.ac.uk
Contact Email: journals.library@nihr.ac.uk
Copyright: 2009 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.